pravastatin has been researched along with Diseases, Peripheral Vascular in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, C; Aronow, WS | 1 |
| Boukriche, Y; Dumas, C; Nangou, P; Oziol, E; Reny, JL; Sedighian, S; Simorre, B | 1 |
| Davis, BR; Meyers, DG; Rouleau, JL; Sacks, FM; Wilt, TJ | 1 |
| Applegate, W; Crouse, J; Davis, KB; Egan, DA; Elam, MB; Garg, R; Herd, JA; Hunninghake, DB; Kostis, JB; Pettinger, MB; Probstfield, J; Sheps, DS; Waclawiw, MA; Wilt, TJ | 1 |
| Azuma, N; Matsugane, T; Motohashi, K; Nishide, T; Nobuto, T; Suzuki, M; Yamane, S | 1 |
| Davis, KB; Egan, DA; Garg, R; Griffin, B; Pettinger, MB; Thomason, T; Waclawiw, MA | 1 |
| Cicco, G; Pirrelli, A; Stingi, GD; Tarallo, MS; Vicenti, P | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Blann, AD; Buggins, P; Gurney, D; Hughes, E; Lip, GY; Silverman, SH | 1 |
1 review(s) available for pravastatin and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Hemorheology and tissue oxygenation in hypertensives with lipoidoproteinosis and peripheral occlusive arterial disease (POAD) treated with sulodexide and pravastatine and evaluated with laser assisted optical rotational red cell analyzer (LORCA) and trans
Topics: Adult; Aged; Blood Gas Monitoring, Transcutaneous; Female; Glycosaminoglycans; Hemorheology; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Laser-Doppler Flowmetry; Lasers; Lipoid Proteinosis of Urbach and Wiethe; Male; Middle Aged; Peripheral Vascular Diseases; Pravastatin | 1999 |
4 trial(s) available for pravastatin and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Coronary Disease; Cross-Sectional Studies; Female; Humans; Intracranial Arteriosclerosis; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Prevalence; Recurrence; Risk Factors; Smoking | 1996 |
Compliance to multiple interventions in a high risk population.
Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Aspirin; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Male; Niacin; Patient Compliance; Peripheral Vascular Diseases; Placebos; Platelet Aggregation Inhibitors; Pravastatin; Time Factors; Warfarin | 1999 |
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome | 2000 |
Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease.
Topics: Aged; Anticholesteremic Agents; C-Reactive Protein; Case-Control Studies; Double-Blind Method; Female; Humans; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Lipids; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Pravastatin; Statistics, Nonparametric; von Willebrand Factor | 2001 |
4 other study(ies) available for pravastatin and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Health Services for the Aged; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; New York; Peripheral Vascular Diseases; Pravastatin; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides | 2002 |
[Medical treatment in peripheral arterial disease: a professional practice study in 262 patients].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medical Records; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Pravastatin; Retrospective Studies; Stroke | 2007 |
Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study.
Topics: Adult; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Niacin; Peripheral Vascular Diseases; Pilot Projects; Pravastatin; Randomized Controlled Trials as Topic; Research Design | 1999 |
Double filtration plasmapheresis maintains normal adhesion molecule levels.
Topics: Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cell Adhesion Molecules; Cholesterol; Disease Progression; Endothelium, Vascular; Filtration; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Intercellular Adhesion Molecule-1; Myocardial Ischemia; Peripheral Vascular Diseases; Plasmapheresis; Pravastatin; Thrombomodulin; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 1998 |